MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
710.98%
Quick Ratio
710.98%
Cash Ratio
372.71%
Debt to Asset Ratio
20.75%
Unit: Thousand (K) dollars
Assets Breakdown
    • Long-term investments
    • Cash and cash equivalents
    • Short-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
274,161 232,185 170,084 211,104
Short-term investments
196,277 228,753 327,750 387,645
Restricted cash and cash equivalents, current
1,925 1,922 2,215 88,218
Equity investments
5,861 6,077 8,679 7,270
Prepaid expenses and other current assets
44,761 45,143 36,956 41,469
Total current assets
522,985 514,080 545,684 735,706
Intangible assets, net
7,777 7,850 7,924 7,998
Goodwill
16,937 16,937 16,937 16,937
Property and equipment, net
53,158 55,620 58,203 60,795
Operating right-of-use assets
60,760 62,099 63,555 64,853
Restricted cash and cash equivalents, noncurrent
6,956 6,963 6,957 6,956
Long-term investments
332,970 314,575 304,212 286,099
Other assets
24,042 24,699 15,981 13,188
Total assets
1,025,585 1,002,823 1,019,453 1,192,532
Deferred revenue, current
NaN NaN 0 10,109
Contingent consideration obligation, current
NaN 0 0 0
Accounts payable
5,445 9,803 6,847 12,234
Accrued and other liabilities
68,113 83,012 68,375 82,661
Total current liabilities
73,558 92,815 75,222 105,004
Deferred revenue, noncurrent
NaN NaN 9,433 NaN
Operating lease liabilities, noncurrent
86,635 89,054 91,215 93,405
Contingent consideration obligation, noncurrent
33,210 34,100 34,180 33,620
Other long-term liabilities
19,417 21,578 13,305 13,031
Total liabilities
212,820 237,547 223,355 245,060
Common stock, 0.0001 par value 300,000,000 shares authorized as of march31, 2026 and december31, 2025 161,234,058 and 139,474,954 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
16 14 14 14
Additional paid-in capital
2,139,698 1,965,090 1,952,843 1,941,386
Accumulated other comprehensive loss
-3,483 -2,057 -1,911 -2,221
Accumulated deficit
-1,323,466 -1,197,771 -1,154,848 -991,707
Total stockholders equity
812,765 765,276 796,098 947,472
Total liabilities and stockholders equity
1,025,585 1,002,823 1,019,453 1,192,532
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$274,161K Short-term investments$196,277K Prepaid expenses andother current assets$44,761K Equity investments$5,861K Restricted cash and cashequivalents, current$1,925K Total current assets$522,985K Long-term investments$332,970K Operating right-of-useassets$60,760K Property and equipment,net$53,158K Other assets$24,042K Goodwill$16,937K Intangible assets, net$7,777K Restricted cash and cashequivalents, noncurrent$6,956K Total assets$1,025,585K Total liabilities andstockholders equity$1,025,585K Total stockholdersequity$812,765K Total liabilities$212,820K Accumulated deficit-$1,323,466K Accumulated othercomprehensive loss-$3,483K Additional paid-in capital$2,139,698K Operating leaseliabilities, noncurrent$86,635K Total currentliabilities$73,558K Contingent considerationobligation, noncurrent$33,210K Other long-termliabilities$19,417K Common stock, 0.0001par value...$16K Accrued and otherliabilities$68,113K Accounts payable$5,445K

Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. (VIR)